Peter A Andrews

Nephrocardiology — a theme for the future?
The British Journal of Diabetes & Vascular Disease 2002 2: 75. [PDF]  

David C Wheeler

Protecting the kidneys and cardiovascular system in type 2 diabetes
The British Journal of Diabetes & Vascular Disease 2002 2: 77-79. [PDF] [References]  

James D Walker

Review: Angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in diabetic renal disease
The British Journal of Diabetes & Vascular Disease 2002 2: 81-84. [Abstract] [PDF] [References]  

Simon J Davies

Review: The epidemic of diabetic renal disease — the practical challenges for renal replacement programmes
The British Journal of Diabetes & Vascular Disease 2002 2: 86-89. [Abstract] [PDF] [References]  

Cathy J Hay and Philip A Kalra

Review: Renovascular disease in diabetic patients
The British Journal of Diabetes & Vascular Disease 2002 2: 91-95. [Abstract] [PDF] [References]  

Hugh Gallagher and Peter A Andrews

What is diabetic renal disease?
The British Journal of Diabetes & Vascular Disease 2002 2: 96-100. [Abstract] [PDF] [References]  

Rudy W Bilous

Angiotensin II receptor blockade and type 2 diabetic nephropathy
The British Journal of Diabetes & Vascular Disease 2002 2: 101-105. [Abstract] [PDF] [References]  

Mike Kirby

Screening for microalbuminuria
The British Journal of Diabetes & Vascular Disease 2002 2: 106-109. [PDF] [References]  

Mike Page

Diabetic renal disease: who to refer, when to refer
The British Journal of Diabetes & Vascular Disease 2002 2: 112-114. [PDF] [References]  

James E Marsh and Peter A Andrews

Management of the diabetic patient approaching end-stage renal failure
The British Journal of Diabetes & Vascular Disease 2002 2: 121-126. [PDF] [References]  

Peter A Andrews and Stephen JD Brecker

Premature atherosclerosis associated with diabetic renal disease
The British Journal of Diabetes & Vascular Disease 2002 2: 128-129. [PDF] [References]  

Nicola Joss, Kenneth R Paterson, Christopher J Deighan, Keith Simpson, and J Michael Boulton-Jones

Vascular disease and survival in patients with type 2 diabetes and nephropathy
The British Journal of Diabetes & Vascular Disease 2002 2: 137-142. [Abstract] [PDF] [References]  

Karl Winkler, Isolde Friedrich, Manfred W Baumstark, Heinrich Wieland, and Winfried März

Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus
The British Journal of Diabetes & Vascular Disease 2002 2: 143-148. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.